Latest News:
back to top



Our Trustee Board is made up of people with a wide range of skills and experience. Several of our Trustees have personal experience of liver disease; others have worked in related fields and/or have skills essential for the British Liver Trust.

Wim Bushell - Chairman

W Wim has worked in the City of London since 1974 as a broker at Lloyd's of London, at Greig Fester, then Morgan Read & Coleman as an Executive Director before selling the business to Arthur J Gallagher International in 1996, where Wim has had various roles in the organisation, including CEO of reinsurance and now Deputy Chairman of Arthur J Gallagher.  Wim is also governor of two schools, one in the independent sector, the other is a state school in the East End of London.

Martin Newlan - Treasurer

Martin trained with a city firm of accountants before becoming a management trainee with a West Midlands engineering group, becoming chief accountant with its Kent-based subsidiary. In 1973 he established a plastics manufacturing business, serving first as Finance Director and eventually as Managing Director. The business became a leading manufacturer of drug delivery devices and pharmaceutical packaging. In 2002 he joined Cumberland Lodge, an educational charity and unique conference centre in the heart of Windsor Great Park as Bursar, from where he has recently retired. His previous charitable interests included serving as treasurer of Caterham School for 20 years and volunteering extensively with St John Ambulance. He is currently a trustee of two grant-making charities and volunteers with the National Trust. Martin is married to Julia and they have three children and six grandchildren.

Dr Stephen Ryder

Since June 1994 Dr Ryder has been a consultant Physician in Hepatology and Gastroenterology at the Nottingham Digestive Diseases Centre, Nottingham University Hospitals NHS Trust (NUH). He graduated from Nottingham University Medical School and trained in hepatology at St Mary’s and Kings College Hospitals in London.His major clinical and research interest is Hepatitis C infection. Dr Ryder was the national lead for the Hepatology Clinical Research Network until 2015 and is the East Midlands lead for Division 6 of the CRN. Dr Ryder became the Director of Research and Innovation at NUH in January 2016.

 Diana Gornall

Following a recent merger, Di is now the Director of Voluntary and Statutory Income at Arthritis Research UK (was the Director of Fundraising at Arthritis Care).She started her career in a software house -  developing solutions for blue chip companies before moving into pure event management and finally fundraising at the MS Society. Thanks to this unusual career mix, Di comes with skills in technology, project management and data control as well as fundraising, change management and leadership. Di is a member of the Institute of Fundraising and sits on their Learning and Development committee.  Outside of work, Di destresses on the badminton court (in London) or climbing mountains (outside of London!).

David Meek

David has over 30 years’ experience in financial markets, governance, risk and controls as a former senior Managing Director at large global institutions including JPMorgan and Citi. David is a Non-Executive Board Director and sub-committee Chair of several publicly listed and non-listed organisations globally. Most recently he has taken up the role of Vice Chairman of NCB Capital, one of the largest Investment Banks and Asset Managers in the Middle East.His business interests run across industries including finance, real estate, innovation and technology, and has worked directly with start ups through to the industry regulators.David has always been proactively involved in the voluntary and charity sectors. He is Chairman of the charity Getting on Board and a mentor at Cambridge University on their Enterprise Programme.

Toby McMaster

Toby has worked in digital marketing at a leading London agency, helping a range of companies grow, including a leading UK food delivery start-up and a social enterprise focused on access to higher education. He now works in public sector consultancy supporting hospitals and other healthcare bodies from operational level processes to high level strategy.Toby recently co-founded Vesalian, a start-up focused on the communication of healthcare risk in an intuitive and actionable manner. Vesalian aims to support informed shared decision making between patients and healthcare professionals.Toby has a background in communications, including experience in the Central Department of Communications at the World Health Organization, where he completed an internship supporting the inaugural World Antibiotic Awareness Week. He studied Natural Sciences at the University of Cambridge, focusing on pharmacology, whilst taking on the role of Editor-in-chief of Polygeia, a student run global health think tank.Toby has had biliary atresia since birth and has experience of the impact of a liver condition on the lives of patients, as well as the lack of awareness of these conditions that can exist within primary care.

Neil McClements

Neil is a serial software entrepreneur whose businesses have delivered high-profile technology solutions for clients in media, banking, telecoms & financial services. He is an experienced, hands-on senior executive with extensive stakeholder, client-facing project/programme management skills. Neil has over 20 years’ experience of building organisations from early stage through to sustainable operational revenues through to acquisition. Over the past 2 years, Neil has become increasingly involved in the voluntary / healthcare sector advising small charities in conjunction with the Foundation for Social Improvement and serving as trustee/board member for Haemochromatosis UK.

Christopher Exeter

Christopher is a data scientist, and recently completed a role as Director of Research & Development at UnitedHealth Group, where his work involved developing technological interventions to prevent Non Communicable Disease.  Before UnitedHealth Group, he was a Senior Fellow in the Faculty of Medicine at Imperial College London, based at St Mary's Hospital.  His work involved leading an international research project aimed at both evaluating existing, and developing new, innovations to tackle Non Communicable Disease.  Prior to this role he was a Senior Civil Servant at both the Department of Health and the former Department of Business, Innovation and Skills; his roles included Private Secretary to a Minister and to a Director General, Policy Lead to the Director General of Research & Development, Deputy Policy Director to the NHS Medical Director and a Director of Policy in the Innovation Directorate at the Department of Business, Innovation & Skills.  Before becoming a civil servant he worked in corporate finance at Deloitte.  He holds a PhD in health technology and is a Honorary Senior Fellow in the School of Life and Medical Sciences at University College London. He is an Expert Member of the NHS Health Research Authority's London Bloomsbury Research Ethics Committee and a Review for the National Institute for Health Research.